Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Parkin

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|October 24, 2002
Phenotypic and genotypic HIV-1 drug resistance assays provide complementary informationNeil Parkin, Colombe Chappey, Laura Maroldo, et al.
Viruses|May 24, 2020
External Quality Assessment Program for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Logistical ConsiderationsHezhao Ji, Neil Parkin, Feng Gao, et al.
Journal of Clinical Microbiology|December 16, 2011
Comparison of HIV-1 RNA measurements obtained by using plasma and dried blood spots in the automated abbott real-time viral load assayMiguel Arredondo, Carolina Garrido, Neil Parkin, et al.
Viruses|June 11, 2020
Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation ConsiderationsSantiago Ávila-Ríos, Neil Parkin, Ronald Swanstrom, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2012
Evaluation of in-house genotyping assay performance using dried blood spot specimens in the Global World Health Organization laboratory networkNeil Parkin, Carmen de Mendoza, Rob Schuurman, et al.
Journal of Clinical Microbiology|January 17, 2014
Sequence conservation of the region targeted by the Abbott RealTime HCV viral load assayGavin Cloherty, Neil Parkin, James Rhoads, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2006
Identification and structural characterization of I84C and I84A mutations that are associated with high-level resistance to human immunodeficiency virus protease inhibitors and impair viral replicationHongmei Mo, Neil Parkin, Kent D Stewart, et al.
AIDS Research and Human Retroviruses|September 16, 2011
Sequence quality analysis tool for HIV type 1 protease and reverse transcriptaseAllison K Delong, Mingham Wu, Diane Bennett, et al.
Open Forum Infectious Diseases|March 24, 2026
Re-evaluating the Potential Impact of Preexposure Prophylaxis (PrEP) in Achieving HIV Elimination in the United States: Insights From ModelingJason Baron, Tamar Tchelidze, Neil Parkin, et al.
AIDS (London, England)|March 5, 2008
Evidence for different susceptibility to tipranavir and darunavir in patients infected with distinct HIV-1 subtypesEva Poveda, Carmen de Mendoza, Neil Parkin, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Journal of Acquired Immune Deficiency Syndromes (1999)|October 24, 2002
Phenotypic and genotypic HIV-1 drug resistance assays provide complementary informationNeil Parkin, Colombe Chappey, Laura Maroldo, et al.
Viruses|May 24, 2020
External Quality Assessment Program for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Logistical ConsiderationsHezhao Ji, Neil Parkin, Feng Gao, et al.
Journal of Clinical Microbiology|December 16, 2011
Comparison of HIV-1 RNA measurements obtained by using plasma and dried blood spots in the automated abbott real-time viral load assayMiguel Arredondo, Carolina Garrido, Neil Parkin, et al.
Viruses|June 11, 2020
Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation ConsiderationsSantiago Ávila-Ríos, Neil Parkin, Ronald Swanstrom, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2012
Evaluation of in-house genotyping assay performance using dried blood spot specimens in the Global World Health Organization laboratory networkNeil Parkin, Carmen de Mendoza, Rob Schuurman, et al.
Journal of Clinical Microbiology|January 17, 2014
Sequence conservation of the region targeted by the Abbott RealTime HCV viral load assayGavin Cloherty, Neil Parkin, James Rhoads, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2006
Identification and structural characterization of I84C and I84A mutations that are associated with high-level resistance to human immunodeficiency virus protease inhibitors and impair viral replicationHongmei Mo, Neil Parkin, Kent D Stewart, et al.
AIDS Research and Human Retroviruses|September 16, 2011
Sequence quality analysis tool for HIV type 1 protease and reverse transcriptaseAllison K Delong, Mingham Wu, Diane Bennett, et al.
Open Forum Infectious Diseases|March 24, 2026
Re-evaluating the Potential Impact of Preexposure Prophylaxis (PrEP) in Achieving HIV Elimination in the United States: Insights From ModelingJason Baron, Tamar Tchelidze, Neil Parkin, et al.
AIDS (London, England)|March 5, 2008
Evidence for different susceptibility to tipranavir and darunavir in patients infected with distinct HIV-1 subtypesEva Poveda, Carmen de Mendoza, Neil Parkin, et al.
Pageof 7